Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001640334-19-000555
Filing Date
2019-04-09
Accepted
2019-04-09 13:20:16
Documents
45
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K devv_10k.htm 10-K 340635
2 CERTIFICATION devv_ex311.htm EX-31.1 8006
3 CERTIFICATION devv_ex321.htm EX-32.1 3418
  Complete submission text file 0001640334-19-000555.txt   1775651

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT jbct-20181231.xml EX-101.INS 246808
5 XBRL TAXONOMY EXTENSION SCHEMA jbct-20181231.xsd EX-101.SCH 24385
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE jbct-20181231_cal.xml EX-101.CAL 34077
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE jbct-20181231_def.xml EX-101.DEF 58247
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE jbct-20181231_lab.xml EX-101.LAB 141745
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE jbct-20181231_pre.xml EX-101.PRE 127020
Mailing Address 500 NORTH MICHIGAN AVENUE #600 CHICAGO IL 89015
Business Address 500 NORTH MICHIGAN AVENUE #600 CHICAGO IL 89015 (773) 236-8132
BIOSCIENCE NEUTRACEUTICALS, INC. (Filer) CIK: 0001555995 (see all company filings)

EIN.: 460745348 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36604 | Film No.: 19739089
SIC: 5900 Retail-Miscellaneous Retail